Biotinylated Human DLL4 Protein, Fc,Avitag™, premium grade

ユーザーレビュー
製品番号/仕様
価格
数量
DL4-H82F7-25ug
$188.00
DL4-H82F7-200ug
$708.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Synonyms

    DLL4, Delta4

  • Source

    Biotinylated Human DLL4 Protein, Fc,Avitag, premium grade (DL4-H82F7) is expressed from human 293 cells (HEK293). It contains AA Ser 27 - Pro 524 (Accession # NP_061947.1).

    Predicted N-terminus: Ser 27

    It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage. When ready to transition into later clinical phases, we also offer a custom GMP protein service that tailors to your needs. We will work with you to customize and develop a GMP-grade product in accordance with your requests that also meets the requirements for raw and ancillary materials use in cell manufacturing of cell-based therapies.

    Request for sequence
  • Molecular Characterization

    DLL4 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a human IgG1 Fc tag at the C-terminus, followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 82.4 kDa. The protein migrates as 98 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Biotinylation

    As determined by Quantitative ELISA binding assay against streptavidin.

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Host Cell Protein

    <0.5 ng/µg of protein tested by ELISA.

  • Host Cell DNA

    <0.02 ng/μg of protein tested by qPCR.

  • Sterility

    Negative

  • Mycoplasma

    Negative

  • Purity

    >95% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 24 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • SDS-PAGE

    DLL4 SDS-PAGE

    Biotinylated Human DLL4 Protein, Fc,Avitag, premium grade on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    DLL4 SEC-MALS

    The purity of Biotinylated Human DLL4 Protein, Fc,Avitag, premium grade (Cat. No. DL4-H82F7) is more than 95% and the molecular weight of this protein is around 165-205 kDa verified by SEC-MALS.

    Report
  • Bioactivity-CELL BASE

     DLL4 CELL

    Biotinylated Human DLL4 Protein, Fc, Avitag, premium grade (Cat. No. DL4-H82F7) stimulates Human Notch1 (Luc) HeLa Reporter Cell. The EC50 of the effect is 7.10 µg/mL (Routinely tested).

    Protocol
  • Bioactivity-ELISA

     DLL4 ELISA

    Immobilized Human NOTCH1, Fc Tag (Cat. No. NO1-H5255) at 5 μg/mL (100 μL/well) can bind Biotinylated Human DLL4 Protein, Fc,Avitag, premium grade (Cat. No. DL4-H82F7) with a linear range of 2-16 ng/mL (QC tested).

    Protocol
  •  DLL4 ELISA

    Immobilized Biotinylated Human DLL4 Protein, Fc,Avitag, premium grade (Cat. No. DL4-H82F7) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Monoclonal Anti-Human DLL4 Antibody, Human IgG1 with a linear range of 1-16 ng/mL (Routinely tested).

    Protocol

ユーザーレビュー
コメントを投稿

バックグランド

Delta-like protein 4 (DLL4) is also known as Drosophila Delta homolog 4 (Delta4), which contains one DSL domain and eight EGF-like domains. DLL4 is expressed in vascular endothelium. DLL4 is involved in the Notch signaling pathway as Notch ligand, which can activates NOTCH1 and NOTCH4. DLL4 is involved in angiogenesis and negatively regulates endothelial cell proliferation and migration and angiogenic sprouting. DLL4 can bind to Notch-1 and Notch-4.

最新の進展

 
医薬品開発の進捗
  • 英語名:

    Delta-like protein 4

  • カテゴリ:

  • 市販の医薬品数:

    0 詳細

  • 治験医薬品数:

    3 詳細

  • 最新の開発ステージ:

    Phase 3 Clinical

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8